CXCL8 and colorectal carcinoma: Q8 treatment of CRC ex vivo explants showed no significant difference in expression of IL-4 (Figure 3), IL1-þ, IL-2, IL-6, IL-8, IL-10, IL-12p70, IL-13, IFN-γ and TNF-α (Figure 4) in the inflammatory panel.